Receptor homodimerization plays a critical role in a novel dominant negative P2RY12 variant identified in a family with severe bleeding. (2nd December 2017)

• Record Type: Journal Article
• Authors: Mundell, S. J.; Rabbolini, D.; Gabrielli, S.; Chen, Q.; Aungraheeta, R.; Hutchinson, J. L.; Kilo, T.; Mackay, J.; Ward, C. M.; Stevenson, W.; Morel‐Kopp, M.‐C.
• Is Part Of: Journal of thrombosis and haemostasis. Volume 16:Number 1(2018)
• Page Start: 44
• Page End: 53
• Publication Date: 2017-12-02
• Subjects: blood platelet disorder -- human -- inherited -- P2RY12 -- platelet dysfunction; Thrombosis -- Periodicals; Hemostasis -- Periodicals; Blood coagulation disorders -- Periodicals; 616.1
• DOI: 10.1111/jth.13900
• Languages: English
• ISSNs: 1538-7933

Abstract

Abstract : Essentials Three dominant variants for the autosomal recessive bleeding disorder type‐8 have been described. To date, there has been no phenotype/genotype correlation explaining their dominant transmission. Proline plays an important role in P2Y12R ligand binding and signaling defects. P2Y12R homodimer formation is critical for the receptor function and signaling. Summary: Background: Although inherited platelet disorders are still underdiagnosed worldwide, advances in molecular techniques are improving disease diagnosis and patient management. Objective: To identify and characterize the mechanism underlying the bleeding phenotype in a Caucasian family with an autosomal dominant P2RY12 variant. Methods: Full blood counts, platelet aggregometry, flow cytometry and western blotting were performed before next‐generation sequencing (NGS). Detailed molecular analysis of the identified variant of the P2Y12 receptor (P2Y12R) was subsequently performed in mammalian cells overexpressing receptor constructs. Results: All three referred individuals had markedly impaired ADP‐induced platelet aggregation with primary wave only, despite normal total and surface P2Y12R expression. By NGS, a single P2RY12 :c.G794C substitution (p.R265P) was identified in all affected individuals, and this was confirmed by Sanger sequencing. Mammalian cell experiments with the R265P‐P2Y12R variant showed normal receptor surface expression versus wild‐type (WT) P2Y12R. Agonist‐stimulated R265P‐P2Y12R function (both signaling and surface receptor loss) was reduced versus WT P2Y12R. Critically, R265P‐P2Y12R acted in a dominant negative manner, with agonist‐stimulated WT P2Y12R activity being reduced by variant coexpression, suggesting dramatic loss of WT homodimers. Importantly, platelet P2RY12 cDNA cloning and sequencing in two affected individuals also revealed three‐fold mutant mRNA overexpression, decreasing even further the likelihood of WT homodimer formation. R265 located within extracellular loop 3 (EL3) is one of four residues that are important for receptor functional integrity, maintaining the binding pocket conformation and allowing rotation following ligand binding. Conclusion: This novel dominant negative variant confirms the important role of R265 in EL3 in the functional integrity of P2Y12R, and suggests that pathologic heterodimer formation may underlie this family bleeding phenotype.